Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00363597 · ClinicalTrials.gov registry record
Intestinal Permeability in Children/Adolescents With Functional Dyspepsia
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 42
- Enrollment target
NCT00363597: Completed study, sponsored by Children's Mercy Hospital Kansas City.
NCT00363597 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00363597 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The main purpose of this study is to evaluate whether intestinal permeability and/or serum zonulin concentration is increased in children/adolescents with functional dyspepsia (FD). The study will also explore the relationships between intestinal permeability, mucosal inflammation and anxiety in FD patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2006-08 |
| Est. Completion | 2010-07 |
What the finished NCT00363597 record still lists
NCT00363597 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00363597 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00363597 about?
NCT00363597 is a clinical study titled "Intestinal Permeability in Children/Adolescents With Functional Dyspepsia". The main purpose of this study is to evaluate whether intestinal permeability and/or serum zonulin concentration is increased in children/adolescents with functional dyspepsia (FD). The study will also explore the relationships between intestinal permeability, mucosal inflammation and anxiety in FD ...
What is the current status of trial NCT00363597?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2006-08. Estimated completion is 2010-07.
Who is sponsoring clinical trial NCT00363597?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia